• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VSTM

VSTM

Verastem, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.62

-0.19 (-4.99%)

Rating:C-

Company Profile

CEO

Daniel W. Paterson

IPO Date

2012-01-27

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.80

Prev. Close

$3.81

Day Low

$3.58

Day High

$3.84

52W Low

$3.58

52W High

$11.25

Market Cap

$0.25B

Volume

2.39M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

44.5%

Avg Negative

16.4%

Avg Neutral

39.3%

News Feed

Verastem: Catalyst Desert Looms

Seeking Alpha·6/23/2021·↑ positive

Verastem (VSTM) Enters Overbought Territory

Zacks Investment Research·6/11/2021·↓ negative

These Penny Stocks Hit it Big Yesterday, Here's Why

PennyStocks·5/25/2021·↓ negative

Why Verastem Stock Is Crushing It Today

The Motley Fool
·5/24/2021
·↑ positive

VSTM Stock Price: Over 20% Increase Explanation

Pulse2·5/24/2021·↑ positive

Verastem's VS-6766/Defactinib Combo Gets Breakthrough Therapy Tag For Ovarian Cancer; BTIG Upgrades Stock

Benzinga·5/24/2021·↑ positive

Verastem: New Assets, New Indications

Seeking Alpha·4/9/2021·↑ positive

Verastem Oncology to Participate in the H.C. Wainwright Global Life Sciences Conference

Business Wire·3/2/2021·↑ positive

Why Verastem Stock Sank Today

The Motley Fool·1/20/2021·↓ negative

Verastem Oncology: Targeting The RAS Pathway To Develop New Cancer Medicines

Seeking Alpha·1/12/2021·↑ positive